Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study

Summary

This study assesses the aerosol delivery characteristics (measured by nebulization time, serum and sputum tobramycin pharmacokinetic parameters) and safety of tobramycin administered for inhalation by PARI eFlow rapid electronic nebulizer (no compressor) vs. PARI LC PLUS Jet Nebulizer (with compressor) in subjects with cystic fibrosis.

Timeline

Start

2006-04

Primary completion

—

Completion

—

Drugs

Indications